{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:52:16Z","timestamp":1789015936523,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.trsl.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T09:48:42Z","timestamp":1603446522000},"page":"100-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer"],"prefix":"10.1016","volume":"229","author":[{"given":"Ashok K.","family":"Dilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon D.","family":"Honick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuleka","family":"Elapavaluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Velankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hima","family":"Makala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Kevin","family":"Hitchens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley M.","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora Heather","family":"Rigatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon A.","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2020.10.005_bib0001","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrclinonc.2015.140","article-title":"Advances in the care of patients with mucinous colorectal cancer","volume":"13","author":"Hugen","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0002","first-page":"e699","article-title":"Prognostic implications of mucinous differentiation in metastatic colorectal carcinoma can be explained by distinct molecular and clinicopathologic characteristics","volume":"17","author":"Khan","year":"2018","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.trsl.2020.10.005_bib0003","first-page":"13","article-title":"Mucinous colorectal adenocarcinoma: clinical pathology and treatment options","volume":"39","author":"Luo","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.trsl.2020.10.005_bib0004","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/01.MP.0000026617.52466.9F","article-title":"MUC2 is a molecular marker for pseudomyxoma peritonei","volume":"15","author":"O'Connell","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0002-9440(10)64211-3","article-title":"Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells","volume":"161","author":"O'Connell","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0006","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0007","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"a consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0008","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0009","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrc1251","article-title":"Mucins in cancer: protection and control of the cell surface","volume":"4","author":"Hollingsworth","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2020.10.005_bib0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/jso.23146","article-title":"Mucin as a therapeutic target in pseudomyxoma peritonei","volume":"106","author":"Choudry","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0011","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.surg.2014.01.011","article-title":"Prognostic implication of mucinous histology in resected colorectal cancer liver metastases","volume":"155","author":"Lupinacci","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.trsl.2020.10.005_bib0012","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/SLA.0000000000000981","article-title":"Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study","volume":"260","author":"Vigano","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/j.trsl.2020.10.005_bib0013","first-page":"142","article-title":"Mucins and tumor resistance to chemotherapeutic drugs","volume":"1846","author":"Jonckheere","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.trsl.2020.10.005_bib0014","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.trsl.2020.10.005_bib0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.addr.2017.10.004","article-title":"Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier","volume":"124","author":"Menzel","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.trsl.2020.10.005_bib0016","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.addr.2017.10.009","article-title":"The role of mucus on drug transport and its potential to affect therapeutic outcomes","volume":"124","author":"Murgia","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.trsl.2020.10.005_bib0017","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.trsl.2020.10.005_bib0018","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","volume":"5","author":"Poole","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.trsl.2020.10.005_bib0019","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1753465812437563","article-title":"N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease","volume":"6","author":"Sadowska","year":"2012","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.trsl.2020.10.005_bib0020","doi-asserted-by":"crossref","first-page":"33329","DOI":"10.18632\/oncotarget.5259","article-title":"Depletion of mucin in mucin-producing human gastrointestinal carcinoma: results from in vitro and in vivo studies with bromelain and N-acetylcysteine","volume":"6","author":"Amini","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2020.10.005_bib0021","first-page":"92","article-title":"Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy","volume":"33","author":"Amini","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.trsl.2020.10.005_bib0022","first-page":"495","article-title":"Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters","volume":"4","author":"Akhter","year":"2014","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.trsl.2020.10.005_bib0023","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ijc.28380","article-title":"A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei","volume":"134","author":"Pillai","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trsl.2020.10.005_bib0024","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/cam4.2847","article-title":"Rational application of targeted therapeutics in mucinous colon\/appendix cancers with positive predictive factors","volume":"9","author":"Dilly","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.trsl.2020.10.005_bib0025","doi-asserted-by":"crossref","first-page":"106888","DOI":"10.18632\/oncotarget.22455","article-title":"Targeting G-protein coupled receptor-related signaling pathway in a murine xenograft model of appendiceal pseudomyxoma peritonei","volume":"8","author":"Dilly","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.trsl.2020.10.005_bib0026","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkl051","article-title":"Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei","volume":"34","author":"Liedert","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2020.10.005_bib0027","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2613.2010.00721.x","article-title":"Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma","volume":"91","author":"Mavanur","year":"2010","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0028","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1245\/s10434-018-6823-9","article-title":"Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies","volume":"25","author":"Choudry","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0029","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jso.23547","article-title":"Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"109","author":"Blackham","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0030","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2020.10.005_bib0031","article-title":"Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.10.005_bib0032","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.canlet.2009.08.001","article-title":"Bromelain's activity and potential as an anti-cancer agent: current evidence and perspectives","volume":"290","author":"Chobotova","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.trsl.2020.10.005_bib0033","doi-asserted-by":"crossref","first-page":"e30831","DOI":"10.1371\/journal.pone.0030831","article-title":"Inhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytes","volume":"7","author":"Dave","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2020.10.005_bib0034","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/19768354.2018.1512521","article-title":"Bromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosis","volume":"22","author":"Park","year":"2018","journal-title":"Anim Cells Syst (Seoul)"},{"key":"10.1016\/j.trsl.2020.10.005_bib0035","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/215158","article-title":"The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies","volume":"2010","author":"Sobolewski","year":"2010","journal-title":"Int J Cell Biol"},{"key":"10.1016\/j.trsl.2020.10.005_bib0036","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/10715762.2018.1468564","article-title":"N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why","volume":"52","author":"Aldini","year":"2018","journal-title":"Free Radic Res"},{"key":"10.1016\/j.trsl.2020.10.005_bib0037","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/antiox8050111","article-title":"Medical and dietary uses of N-acetylcysteine","volume":"8","author":"Salamon","year":"2019","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.trsl.2020.10.005_bib0038","first-page":"30913","article-title":"A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study","volume":"19","author":"Valle","year":"2019","journal-title":"Eur J Surg Oncol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420302462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524420302462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:41:55Z","timestamp":1761828115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524420302462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":38,"alternative-id":["S1931524420302462"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2020.10.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}